Avantax Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.09M | Buy |
6,762
+754
| +13% | +$122K | 0.01% | 1115 |
|
2025
Q1 | $1.02M | Sell |
6,008
-2,679
| -31% | -$456K | 0.01% | 1081 |
|
2024
Q4 | $1.44M | Buy |
8,687
+4,655
| +115% | +$774K | 0.01% | 878 |
|
2024
Q3 | $693K | Buy |
4,032
+298
| +8% | +$51.2K | ﹤0.01% | 1212 |
|
2024
Q2 | $575K | Buy |
3,734
+316
| +9% | +$48.7K | ﹤0.01% | 1281 |
|
2024
Q1 | $526K | Buy |
3,418
+21
| +0.6% | +$3.23K | ﹤0.01% | 1010 |
|
2023
Q4 | $537K | Buy |
3,397
+917
| +37% | +$145K | 0.01% | 953 |
|
2023
Q3 | $363K | Sell |
2,480
-177
| -7% | -$25.9K | ﹤0.01% | 1087 |
|
2023
Q2 | $407K | Buy |
2,657
+136
| +5% | +$20.8K | ﹤0.01% | 1029 |
|
2023
Q1 | $391K | Sell |
2,521
-29
| -1% | -$4.5K | ﹤0.01% | 1016 |
|
2022
Q4 | $393K | Buy |
2,550
+295
| +13% | +$45.5K | 0.01% | 975 |
|
2022
Q3 | $298K | Sell |
2,255
-25
| -1% | -$3.3K | ﹤0.01% | 1016 |
|
2022
Q2 | $309K | Sell |
2,280
-99
| -4% | -$13.4K | ﹤0.01% | 991 |
|
2022
Q1 | $353K | Sell |
2,379
-2,857
| -55% | -$424K | ﹤0.01% | 929 |
|
2021
Q4 | $848K | Sell |
5,236
-6,464
| -55% | -$1.05M | 0.01% | 570 |
|
2021
Q3 | $1.93M | Sell |
11,700
-3,155
| -21% | -$521K | 0.03% | 340 |
|
2021
Q2 | $2.56M | Sell |
14,855
-2,543
| -15% | -$438K | 0.05% | 284 |
|
2021
Q1 | $2.79M | Sell |
17,398
-1,310
| -7% | -$210K | 0.06% | 238 |
|
2020
Q4 | $3.14M | Sell |
18,708
-539
| -3% | -$90.6K | 0.07% | 186 |
|
2020
Q3 | $3.04M | Buy |
19,247
+3,502
| +22% | +$553K | 0.05% | 278 |
|
2020
Q2 | $2.65M | Buy |
15,745
+2,926
| +23% | +$492K | 0.08% | 181 |
|
2020
Q1 | $1.69M | Buy |
12,819
+7,631
| +147% | +$1M | 0.05% | 216 |
|
2019
Q4 | $764K | Buy |
5,188
+3,398
| +190% | +$500K | 0.02% | 389 |
|
2019
Q3 | $224K | Buy |
+1,790
| New | +$224K | 0.01% | 511 |
|
2019
Q2 | – | Sell |
-1,350
| Closed | -$204K | – | 529 |
|
2019
Q1 | $204K | Buy |
+1,350
| New | +$204K | 0.01% | 458 |
|